The 100 questions everyone asks.

A peptide is a short chain of amino acids, the same building blocks that make up proteins. Your body makes thousands of them, including insulin and many hormones. A peptide medicine is a lab-made copy or variation of one of those signals. Some are among the best-studied drugs in the world; others have only been tested in animals.

No. Anabolic steroids are fat-based hormone molecules. Peptides are chains of amino acids that act on receptors, often by telling your body to release its own hormones. Some growth-hormone peptides are still banned in tested sport, so “not a steroid” does not mean “allowed” or “harmless.”

The grade is the strength of human evidence for a specific use. A: large randomized trials and FDA approval. B: real human trials that are smaller, shorter, or for a different use. C: mostly animal or lab data, with a few small human studies. D: mostly mechanism, marketing or anecdote. A low grade means “we don’t know yet,” not “useless.”

The GLP-1 family: semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro). They have large randomized trials, FDA approval, and in semaglutide’s case, fewer heart attacks and strokes in the SELECT trial. Nothing sold as a “wellness peptide” comes close.

Because the questions that matter most are about the heart, blood pressure, blood sugar, and what else you take. GLP-1 medicines now have cardiovascular outcome data, growth-hormone peptides can raise glucose and fluid, and some peptides raise blood pressure. Dr. Emrani has spent nearly thirty years preventing heart attacks; he brings that rigor to every prescription.

An in-person exam and baseline labs before any prescription, an evidence grade on every option, single-ingredient products from licensed pharmacies only, and a written stop rule before you start. No questionnaire-only prescribing, no blends, no stacks and no discount codes.

Some do and some don’t. GLP-1 medicines reduce appetite within days, with weight change over months. Most other peptides are claimed to work over weeks, which is exactly when time, rest and expectation also make people feel better. That’s why we measure before and after.

Most peptides are digested like food, so they’re injected. Exceptions are designed to survive the gut, such as semaglutide tablets, and a few peptides taken orally for gut effects. Under the 2026 HHS policy, any oral compounded form must come with proof it is absorbed in humans.

A stack is several peptides started together, often sold as a longevity or recovery bundle. We don’t prescribe them. If you start five things at once and feel better or worse, you can’t tell which one did it, and side effects are impossible to trace.

It depends entirely on which peptide, which dose, who makes it, and who is taking it. FDA-approved peptides have known safety profiles from thousands of patients. Most wellness peptides have little human safety data, especially long-term. “Natural” describes where a molecule comes from, not what a dose does.

Our stop groups: pregnancy, trying to conceive or breastfeeding; active cancer or a cancer history without your oncologist’s approval; athletes in drug-tested sport; uncontrolled heart disease; serious kidney or liver disease; immune suppression; and anyone with a prior severe reaction to an injection. The 2-minute safety check on our homepage walks through them.

We don’t know for most of them, which is the problem. Several popular peptides promote growth of blood vessels or raise growth signals like IGF-1, which in theory could help an existing cancer grow. That’s why we require up-to-date cancer screening and avoid growth-promoting peptides in anyone with a cancer history.

Injection-site redness or a small bump, headache, flushing and fatigue for many peptides. Nausea, constipation and fullness for GLP-1 medicines. Water retention, tingling and higher blood sugar for growth-hormone peptides. Most fade; new or severe symptoms mean a same-day call.

Yes. Reactions can appear after several uneventful doses, and a compounded product can contain impurities you react to. Hives, widespread itching or a rash means stop and call the same day. Swelling of the lips, face or throat, or trouble breathing means call 911.

Injecting a product of unknown origin. Purity tests on “research” vials don’t check for sterility or bacterial toxins (endotoxin), which cause the infections and fevers we see. The second most dangerous mistake is guessing the dose, for example confusing mg with mcg, which is a thousand-fold error.

No. Doubling a dose can turn a small risk into a serious one, and for many peptides there’s no evidence that higher doses work better at all. With GLP-1 medicines, faster escalation mainly means more vomiting and dehydration.

Often yes, but it has to be checked. GLP-1 medicines lower blood pressure and can change how quickly pills are absorbed; bremelanotide raises blood pressure briefly; growth-hormone peptides can cause fluid retention. Bring your full medication list to your visit.

Injection under the skin is usually possible on blood thinners, with more bruising. Some peptides are claimed to affect blood-vessel growth or clotting, with little human data. We review each one individually before prescribing.

Don’t hide it; tell us. Bring the vial, the label and your dosing log to your visit. We’ll look at what it really is, check labs, and decide together whether to stop, switch to a licensed product, or replace it with something better proven. No judgment.

Chest pain, trouble breathing, swelling of the face, lips or throat, fainting, confusion, or signs of stroke. Don’t wait to see if it passes, and don’t call the clinic first.

In the main trials, average weight loss was roughly 15% with semaglutide 2.4 mg and around 20% with the highest tirzepatide dose over about 72 weeks. In the STEP UP trial, semaglutide 7.2 mg (Wegovy HD) averaged about 21%. Averages hide a wide range; some people lose much more, some much less.

Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both GLP-1 and GIP receptors. In trials, tirzepatide produced somewhat more weight loss on average. Semaglutide has published heart-outcome data in people with heart disease and excess weight. The right choice depends on your goals, history, tolerance and coverage.

A 7.2 mg weekly dose of semaglutide, approved by the FDA on March 19, 2026. It’s for people who need more weight reduction after at least four weeks on 2.4 mg. It produced more weight loss than 2.4 mg in the STEP UP trial, with more stomach side effects and more reports of skin sensitivity or burning.

All rapid weight loss costs some lean mass. Strength training two to three times a week and protein at every meal limit it substantially. We track strength and body composition, not just the scale. A growth-hormone peptide is not a substitute for lifting.

In trials, most people regained much of the lost weight within a year of stopping. That’s why we plan the long game from day one: the lowest dose that works, strength and protein habits, and a careful taper if you stop.

No. Brand Wegovy is FDA-approved and made under strict manufacturing rules. Compounded semaglutide is not FDA-approved, and since the national shortage ended, broad compounding of copies is restricted. We prescribe the FDA-approved products for weight loss.

Retatrutide is an investigational triple-hormone drug with impressive Phase 3 trial results, but it is not FDA-approved. Anything sold online as retatrutide is gray-market, and you cannot know what’s in it. We don’t prescribe it before approval.

Per the labels, adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure, high cholesterol, sleep apnea or diabetes. We also check for reasons not to use them, such as a personal or family history of medullary thyroid cancer.

Semaglutide reduced heart attacks, strokes and cardiovascular death by about 20% in the SELECT trial of people with heart disease and excess weight, without diabetes. It’s one reason a cardiologist cares about these drugs. Benefits in people without heart disease are still being studied.

Uncommon but important: pancreatitis, gallbladder disease, dehydration and kidney injury from vomiting, and a boxed warning about thyroid C-cell tumors seen in rodents. Severe or persistent belly pain is a same-day call. We screen for risk factors before starting.

Tell your surgeon and anesthesiologist. Because these drugs slow stomach emptying, many surgical teams ask patients to hold a dose or follow special fasting rules before anesthesia. We coordinate this with your surgical team.

Small amounts are usually tolerated, but alcohol worsens nausea and dehydration, and many patients find they want much less of it. Avoid binge drinking, and never drink when you’re vomiting or can’t keep fluids down.

Coverage varies widely by plan. Medicines approved for diabetes or for heart-risk reduction may be covered when you meet the criteria; weight-loss-only coverage is less common. We check your benefits and tell you the cash options honestly.

Grade C. There are many encouraging animal studies on tendons, muscle and gut healing, and only a handful of small, uncontrolled human studies. There is no randomized human trial showing it heals injuries faster. It may help; we don’t know yet.

Since October 28, 2026, HHS has said it won’t take enforcement action against licensed pharmacies that compound BPC-157 under ten conditions. That’s enforcement discretion, not FDA approval, and the policy is a draft that could change. Research-use-only vials are still not covered.

TB-500 is a lab-made fragment of thymosin beta-4, a protein involved in tissue repair. Thymosin beta-4 itself has some human data as a gel for wounds; the injected fragment has mostly animal data. Grade C. It’s banned in tested sport.

A premixed vial of BPC-157 and TB-500 marketed for injuries. We don’t prescribe it. Blends hide which ingredient caused a reaction, and they are excluded from the 2026 HHS policy, which allows only single-ingredient products.

An accurate diagnosis (often an exam or ultrasound) and a progressive loading program with a physical therapist. For tendon problems, structured loading has the strongest evidence of anything. Peptides, if used at all, come on top of rehab, not instead of it.

No. BPC-157, TB-500 and growth-hormone-releasing peptides are prohibited by the World Anti-Doping Agency. A prescription does not protect you from a positive test.

When we do prescribe one, it’s a defined trial, usually several weeks, with a measurable goal (pain score, range of motion, return to an activity) and a review date. If nothing has changed by the review, we stop.

There’s no good human evidence that peptides rebuild cartilage. Weight loss, strength training, and proven arthritis treatments help most. GLP-1 medicines have shown less knee pain in people with obesity and knee osteoarthritis, largely through weight loss.

No peptide has been shown to make people live longer or age more slowly. Growth-hormone peptides raise IGF-1 but have no trial showing a longer or healthier life. The proven longevity tools are still blood pressure, LDL cholesterol, blood sugar, not smoking, strength, fitness and sleep.

A small peptide made by mitochondria that improved metabolism and exercise capacity in older mice. Human data are very limited. Grade C. It’s one of the six peptides in the 2026 HHS policy, injection only.

Only in cells in a dish and in older, small studies that haven’t been reproduced well. There’s no good evidence it lengthens telomeres or extends life in people. Grade D.

NAD+ is not a peptide; it’s a coenzyme. Raising NAD+ levels is biologically interesting, but human trials so far show limited, inconsistent benefits. Infusions can cause flushing, nausea and chest tightness. We discuss it case by case.

Growth-hormone-releasing peptides that push the pituitary to release more growth hormone. An FDA advisory committee voted against CJC-1295 in December 2024. They raise IGF-1 and can raise blood sugar and cause fluid retention. We don’t prescribe CJC-1295.

A fragment of natural growth-hormone-releasing hormone. It was once FDA-approved for children with growth-hormone deficiency, so its short-term human safety is better known than most. Benefits for healthy aging adults are unproven. Grade B, only with IGF-1 and glucose monitoring.

Fatigue is a symptom, not a diagnosis. Sleep apnea, low iron, thyroid disease, low B12, depression, medications and heart problems are common, treatable causes. We look for those first. Many patients never need a peptide.

Keep blood pressure under control, drive LDL cholesterol low, prevent or treat diabetes, train strength and fitness, sleep seven to nine hours, don’t smoke, keep screening up to date, and stay connected to people. These have far more evidence than any peptide.

Most claims come from animal studies or anecdotes. The things proven to improve training are progressive training, protein, sleep and recovery. If your workouts have stalled, we check iron, thyroid, hormones and heart rate response first.

A copper-binding peptide found naturally in the body. Topical GHK-Cu has small human studies showing improvements in skin firmness and fine lines. Grade B for topical skin use. Injected GHK-Cu has much less human data and isn’t part of the 2026 HHS policy.

Daily sunscreen and a prescription retinoid such as tretinoin. They have decades of evidence. A copper-peptide serum can be a reasonable addition, not a replacement.

Topical peptides have weak evidence for hair. Proven options are minoxidil, finasteride or dutasteride for appropriate patients, and treating causes like low iron or thyroid disease. We’ll tell you which of these fits you.

Melanotan II is an unapproved tanning peptide. It has been linked to new and changing moles and, in case reports, melanoma, plus nausea and spontaneous erections. It isn’t FDA-approved and isn’t covered by the 2026 HHS policy. We don’t prescribe it for any reason.

KPV is a fragment of an anti-inflammatory hormone. It has lab and animal data for skin and gut inflammation and very little human data. Grade D. The 2026 HHS policy covers it only in topical and oral forms.

Rapid weight loss of any kind can make the face look thinner and older. Slower loss, strength training, protein and good skin care help. It’s a cosmetic effect of weight loss, not damage from the drug itself.

A peptide developed in Russia from a fragment of a pituitary hormone, used as a nasal spray for focus and stroke recovery there. Western human trials are scarce. Grade C. Under the 2026 HHS policy, only the nasal form is covered.

A nasal peptide developed in Russia for anxiety. One small randomized trial compared it with a benzodiazepine. It is not FDA-approved and is not covered by the 2026 HHS policy.

Brain fog is a symptom. Poor sleep, sleep apnea, thyroid disease, low B12 or iron, depression, menopause and medications cause most of it. We check those first, because treating the cause works better than any nootropic.

Some peptides are marketed for sleep, but human evidence is thin. A sleep evaluation, including a home sleep test if you snore or wake unrefreshed, finds treatable problems in many patients. Untreated sleep apnea also raises blood pressure and heart risk.

Most people notice no change, and some report fewer cravings, including for alcohol. Regulators reviewed reports of depression and suicidal thoughts and did not find a clear causal link, but any new low mood or dark thoughts should be reported right away.

No peptide has been proven to prevent dementia. Controlling blood pressure, diabetes and cholesterol, exercising, treating hearing loss, sleeping well and staying socially active have the best evidence. GLP-1 medicines are being studied, and early results have been mixed.

Bremelanotide is FDA-approved as Vyleesi for low sexual desire in premenopausal women. It’s injected under the skin before sexual activity, with limits on how often. It can cause nausea, flushing and a brief rise in blood pressure, so it isn’t for people with uncontrolled blood pressure or heart disease.

Erectile problems are often an early warning sign of artery disease, appearing years before a heart attack. A heart-focused check (blood pressure, cholesterol, sugar, sometimes a stress test) can be lifesaving. Then sildenafil or tadalafil, when safe, are proven treatments.

Some are marketed that way, with little human evidence. If you have symptoms of low testosterone, the right first step is two morning blood tests and a search for causes like sleep apnea, weight and medications. Proven testosterone therapy has its own benefits and risks we’d review with you.

Menopause symptoms have well-proven treatments, including menopausal hormone therapy for appropriate women. Peptides marketed for menopause mostly lack human evidence. We start with what’s proven and safe for your heart and breast-cancer risk.

No unapproved peptides while trying to conceive, during pregnancy, or while breastfeeding. GLP-1 medicines should be stopped ahead of a planned pregnancy as the label directs. Tell us early if you’re planning a pregnancy.

Tirzepatide can reduce the absorption of birth-control pills, especially when starting or increasing the dose. The label advises a backup or non-oral method for a period after each increase. Ask us which method fits you.

Add the exact volume of the diluent on your pharmacy label, usually bacteriostatic water, slowly down the inside wall of the vial, then gently swirl until clear. Never shake. Label the vial with the date and concentration and refrigerate. Our Mixing & Protocol guide has the full step-by-step.

Divide the mg in the vial by the mL of water to get the concentration. Units to draw = your dose in mg ÷ concentration × 100 on a U-100 insulin syringe. Our interactive calculator does the math and shows the line on the syringe.

Sterile water with a small amount of benzyl alcohol that slows bacterial growth, which allows a vial to be used for multiple doses. Plain sterile water is for single use. Use whichever your pharmacy label specifies.

1 mg = 1,000 mcg. Mixing them up is a thousand-fold dosing error, and it’s one of the most common mistakes we see. Always read the unit on your prescription twice.

Into the fat under the skin of the belly (at least 2 inches from the navel), the front of the thigh, or the back of the upper arm. Rotate sites each time and avoid scars and bruises.

Usually very little. Insulin needles are short and thin. Letting the alcohol dry, injecting slowly, and using a room-temperature vial make the biggest difference.

Until the beyond-use date on your pharmacy label, in the refrigerator. Many multi-dose vials mixed with bacteriostatic water are dated for up to 28 days, but your label governs. Throw out leftovers after that date.

No. One syringe, one injection. Reuse dulls the needle, causes more pain and bruising, and can contaminate the vial with bacteria.

No. Unless your label says the product is meant to look that way, cloudiness, particles or color change mean contamination or breakdown. Don’t inject it; call the pharmacy.

It depends on the drug. For weekly semaglutide or tirzepatide, the labels give specific windows for taking a late dose versus skipping it. For other peptides, follow your prescription’s instructions or call us. Never double up to catch up.

In your hand luggage, with the pharmacy label, in an insulated pouch with a cold pack that doesn’t touch the vial. Bring a few extra syringes and a small sharps container. Never leave medicine in a hot car.

In an FDA-cleared sharps container, or a heavy plastic bottle with a screw-on cap if you don’t have one. Check your city’s rules for drop-off. Never put loose needles in the trash or recycling.

HHS said it won’t take enforcement action against state-licensed pharmacies and physicians that compound six peptides: BPC-157, TB-500, MOTS-c, Semax, Epitalon and KPV, as long as they meet ten conditions. It’s a draft enforcement-discretion policy, not FDA approval, and it doesn’t say any of the six is safe or effective.

Products sold with a label saying they are not for human use, to get around drug laws. They have no prescription, no pharmacy oversight and often no sterility or endotoxin testing. The 2026 HHS policy doesn’t cover them. We don’t prescribe or administer them.

A licensed pharmacy that prepares medicines for a specific patient with a prescription. 503A pharmacies compound for individual prescriptions; 503B outsourcing facilities make larger batches under stricter manufacturing rules. Compounded drugs are not FDA-approved.

A lab report on a batch of raw ingredient or finished product. A useful COA covers identity, purity, potency, and for injectables, sterility and endotoxin, from a named lab. A “99% pure” COA alone says nothing about bacteria or toxins.

Are you state-licensed? Is this compounded for me by name? Who made the raw ingredient, and is that facility FDA-registered? Can I see the COA, including sterility and endotoxin? What’s the beyond-use date? Is this a single ingredient? Our homepage lists twelve questions.

Only from a state-licensed pharmacy that dispenses to you by name. A website that ships peptides without a prescription, or labels them “not for human use,” is not a pharmacy, whatever it calls itself.

Some are: semaglutide, tirzepatide, liraglutide, bremelanotide, tesamorelin and others, each for specific uses. Most “wellness” peptides, including BPC-157, TB-500, MOTS-c and Epitalon, are not FDA-approved for any use.

The World Anti-Doping Agency prohibits BPC-157, TB-500, growth-hormone-releasing peptides and many others. If you’re in a tested sport, assume any peptide is banned unless your federation confirms otherwise in writing.

Nobody knows. It’s a draft, can be withdrawn without notice, and doesn’t bind state boards of pharmacy or medicine. A second review of other peptides is planned. We’ll update this page as the rules change.

A full history, medication review, blood pressure and an exam where it matters, a review of your goal in one sentence, and a check of the stop groups. We order baseline labs and, if needed, cancer screening. You leave with a plan, which often starts with a 30-day foundation.

Unapproved peptides start with an in-person visit in Tarzana, because an exam and labs matter. Follow-up questions can often be handled by phone or message once you’re established.

Compounded peptides are cash-pay, and prices depend on the pharmacy and product. FDA-approved medicines may be covered by insurance. We give you real numbers before you decide, and we never sell discount-code bundles.

Visits and labs may be billed to insurance where appropriate, and approved medicines may be covered under your plan. Compounded peptides are not covered by insurance. Call (818) 996-4100 to check your plan.

18370 Burbank Blvd, Suite 401, Tarzana, CA 91356. Hours: Monday, Tuesday and Thursday 8:00–5:00; Wednesday and Friday 8:00–2:30. Phone (818) 996-4100.

No. Baseline labs protect you: they catch problems a peptide could worsen and give us something to measure against. Prescribing without them is how online clinics cut costs, not how good medicine works.

Only if it fits your goal, your history and the evidence, and if a licensed pharmacy can supply it as a single ingredient. Sometimes the honest answer is a better-proven option, and sometimes it’s no prescription at all.

Some are helpful: semaglutide lowered heart attacks and strokes in people with heart disease and excess weight. Others need caution: growth-hormone peptides can cause fluid retention, and bremelanotide raises blood pressure briefly. With heart disease, every peptide needs a cardiologist’s review.

Not the wellness peptides. Proven cholesterol medicines include statins, ezetimibe, bempedoic acid, PCSK9 inhibitors and inclisiran (a small-interfering RNA, not a peptide). For many patients, getting LDL low is the single strongest longevity move available.

Several do. GLP-1 medicines tend to lower it, partly through weight loss. Bremelanotide raises it briefly. Growth-hormone peptides can raise it through fluid retention. We measure blood pressure before and during any peptide trial.

Some people report a faster heart rate, which is a known effect of GLP-1 medicines, and stimulant-like effects with some unapproved products. A racing or irregular heartbeat is a same-day call; chest pain or fainting is 911.